Demographic characteristics of Italian and Latino American countries.
| Demographic characteristics | Italy | Latino American countries |
|---|---|---|
| Patients (n) | 330 | 330 in each country |
| Mean age (years) | 43 | 32–36 |
| College/University (%) | 34 | 66–81 |
| Living in a large city (%) | 32 | 71–78 |
| Physicians (n) | 216 | 216 in each country |
| Mean age (years) | 47 | 42–47 |
| Working in a large city (%) | 51 | 81–87 |
| Working within NHS (%) | 68 | 28–33 |
NHS: National Health Service.
RP and DV: Conceptualization, Writing—original draft. FA and CD: Writing—review & editing. GWC: Supervision, Writing—review & editing. All authors read and approved the submitted version.
Giorgio Walter Canonica, who is the Editor-in-Chief of Exploration of Asthma & Allergy, had no involvement in the decision-making or the review process of this manuscript. GWC: reports research or clinical trials grants paid to his Institution from Menarini, AstraZeneca, GSK, Sanofi Genzyme, and fees for lectures or advisory board participation from Menarini, AstraZeneca, Celltrion, Chiesi, Faes Farma, Firma, Genentech, Guidotti-Malesci, GSK, HAL Allergy, Innovacaremd, Novartis, OM Pharma, Red Maple, Sanofi-Aventis, Sanofi-Genzyme, Stallergenes, and Uriach Pharma. RP: former employee and now consultant of GSK. DV: employed by GSK, holds financial equities in GSK. FA: ing and anonFormer employee in GSK. CD: fees for board participations, educational events, consulting fees, presentations from GSK, Menarini, Novartis, Astrazeneca, and Neopharmed.
Since this study was a secondary analysis conducted on an already existing and anonymous database, further submission for review is not required according to the local ethics committee.
Since this study was a secondary analysis conducted on an already existing and anonymous database, informed consent to participate is not required according to the local ethics committee.
Not applicable.
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
The APPaRENT2 study was funded by Glaxo Smith Kline (GSK study [214325]). The founder had no role in the design of this study, data collection and analysis, decision to publish, or preparation of the manuscript.
© The Author(s) 2026.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.